TipRanks
Go Ultimate55% OFF
PC:ARTAN

ARTAN Bio: Valuation, Funding & Investors

ARTAN Bio is a longevity biotechnology company developing engineered suppressor platforms to target nonsense mutations. Its technology aims to restore protein translation disrupted by premature stop codons, addressing a range of aging-related and genetic diseases through mutation-specific codon suppression.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$1M
Total Funding Rounds
2
Latest Funding Amount
$1M
Latest Funding Round
Seed Round

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jul 01, 2026Seed Round$1.00M―
Jun 04, 2026Seed Round$200.00K―

Investors

Investor NameFunding Round
Michael TorresSeed Round

Similar Companies

A snapshot of private companies similar to ARTAN Bio, helping you discover and navigate related company profiles.

Related News and Analysis